ada glp 1 recommendations standards of care 2025 glp-1 receptor agonists Medical in Diabetes: Updates! Although the GLP-1 Medications for Weight Loss:

[15] [14] While mild gastrointestinal symptoms are common and often transient with GLP-1 therapy, certain warning signs warrant prompt medical evaluation

Alteration of retinal metabolism and oxidative stress may implicate myopic eye growth: evidence from discovery and targeted proteomics in an animal model

Then there's Glutathione, which is a superstar antioxidant

Jun 6 2012;15(6):838-847

These products have not been evaluated by the FDA and are not FDA-approved for the treatment of medical conditions

At M6, papilledema was still present in 7 (58.3%) and 19 (76.0%) patients from the GLP-1-RA and UCWM group (Supplementary Table 3)